HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA
Clinical trials for HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
One-Shot wonder? HPV vaccine study could slash cervical cancer rates
⭐️ VACCINE ⭐️ OngoingThis large study tests whether a single dose of the HPV vaccine protects against HPV infection and cervical cancer as effectively as the standard two doses. Nearly 28,000 girls aged 12–16 are taking part. If one dose works, it could make vaccination cheaper and easier, especially…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA
Phase: PHASE4 • Sponsor: National Cancer Institute (NCI) • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 09:00 UTC
-
MRI-Guided radiation aims to improve treatment for HPV cancers
Disease control OngoingThis study tests whether using MRI to guide internal radiation therapy (brachytherapy) can improve treatment for women with HPV-related cervical or vaginal cancers. About 26 participants with advanced-stage cancers will receive standard chemoradiation plus MRI-guided brachytherap…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Could a single HPV shot be enough to prevent cervical cancer?
Prevention OngoingThis study is testing whether a single dose of the HPV vaccine can protect young women aged 18 to 30 from cervical cancer. Currently, two or three doses are recommended, but a single dose could make vaccination easier and cheaper. The trial involves 5,000 women in Costa Rica and …
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA
Phase: PHASE4 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated May 22, 2026 14:01 UTC
-
At-Home HPV test kits at Walk-In clinics could boost cancer screening
Prevention ENROLLING_BY_INVITATIONThis study looks at whether giving women a simple self-collection kit for HPV testing at Express Care clinics (which have evening and weekend hours) can increase the number of women who get screened for cervical cancer. About 500 women ages 30–63 who are overdue for screening wil…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Prevention
Last updated May 13, 2026 16:04 UTC
-
HPV vaccine under the microscope: 10-Year Follow-Up reveals hidden insights
Knowledge-focused OngoingThis study follows thousands of women in Costa Rica who received the HPV vaccine years ago, plus a new group of unvaccinated women, to see how well the vaccine works over time. Researchers are checking for cervical cell changes, immune markers, and whether the vaccine might shift…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 26, 2026 08:32 UTC